MFI:NASDAQmF International Limited Analysis
Data as of 2026-05-22 - not real-time
$9.50
Latest Price
9/10Risk
Risk Level: High
Executive Summary
MFI is trading at $9.50, well below its 20‑day ($10.32) and 50‑day ($10.99) simple moving averages, indicating a bearish price bias. The RSI of 40 suggests the stock is nearing oversold territory, while the MACD histogram has turned marginally positive, hinting at a very weak bullish signal that may not hold given the broader downtrend. Volatility is extreme at over 120% on a 30‑day basis and a beta of 2.68 makes the equity highly sensitive to market swings. Fundamentally, the company is hemorrhaging cash – operating cash flow and free cash flow are both negative, and margins are deeply in the red, with operating margin at –93% and a net loss per share of $2.25. Despite a 20% revenue growth year‑over‑year, the balance sheet shows a debt‑to‑equity ratio above 22, and the Nasdaq non‑compliance notice adds a serious regulatory headwind.
Given the overvalued price‑to‑book (5.5×) and price‑to‑sales (17×) multiples relative to its deteriorating earnings, the stock appears stretched on valuation. The market’s “Extreme Greed” sentiment does not align with the company’s cash‑burn and compliance challenges, suggesting that any upside to the $30 target price is highly speculative and contingent on a turnaround in both operations and listing status.
Given the overvalued price‑to‑book (5.5×) and price‑to‑sales (17×) multiples relative to its deteriorating earnings, the stock appears stretched on valuation. The market’s “Extreme Greed” sentiment does not align with the company’s cash‑burn and compliance challenges, suggesting that any upside to the $30 target price is highly speculative and contingent on a turnaround in both operations and listing status.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price below key moving averages signaling continued downside
- Nasdaq non‑compliance notice raising immediate regulatory risk
- Extreme volatility and high beta amplifying short‑term price swings
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Potential revenue growth if the platform gains market traction
- Need for compliance resolution to stabilize listing status
- High valuation multiples remain a barrier without earnings improvement
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Long‑term upside tied to achieving profitability and cash‑flow positivity
- Strategic importance of Asian fintech market could eventually support valuation
- Persistent cash burn and debt load require significant operational turnaround
Key Metrics & Analysis
Financial Health
Revenue Growth20.80%
Profit Margin-98.87%
P/E Ratio-16.7
ROE-77.91%
ROA-29.16%
Debt/Equity22.15
P/B Ratio5.5
Op. Cash Flow$-6804241
Free Cash Flow$-7857556
Industry P/E39.6
Technical Analysis
TrendBearish
RSI40.2
Support$9.50
Resistance$10.98
MA 20$10.32
MA 50$11.00
MA 200$21.20
MACDBullish
VolumeStable
Fear & Greed Index91.82
Valuation
Target Price$30.00
Upside/Downside215.79%
GradeOvervalued
TypeValue
Risk Assessment
Beta2.68
Volatility120.04%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.